[go: up one dir, main page]

DE59803082D1 - Fanconi-gen ii - Google Patents

Fanconi-gen ii

Info

Publication number
DE59803082D1
DE59803082D1 DE59803082T DE59803082T DE59803082D1 DE 59803082 D1 DE59803082 D1 DE 59803082D1 DE 59803082 T DE59803082 T DE 59803082T DE 59803082 T DE59803082 T DE 59803082T DE 59803082 D1 DE59803082 D1 DE 59803082D1
Authority
DE
Germany
Prior art keywords
polypeptide
fanconi
gen
antibody
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59803082T
Other languages
German (de)
Inventor
Manfred Kubbies
Andreas Machl
Simone Planitzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Priority claimed from PCT/EP1998/001994 external-priority patent/WO1998045428A1/en
Application granted granted Critical
Publication of DE59803082D1 publication Critical patent/DE59803082D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)

Abstract

The present invention concerns a pathophysiologically relevant gene associated with Fanconi anaemia (FA), a polypeptide coded thereby, an antibody directed against the polypeptide as well as the pharmaceutical applications of the nucleic acid, polypeptide and antibody.
DE59803082T 1997-04-07 1998-04-06 Fanconi-gen ii Expired - Lifetime DE59803082D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97105688 1997-04-07
PCT/EP1998/001994 WO1998045428A1 (en) 1997-04-07 1998-04-06 Fanconi-gen ii

Publications (1)

Publication Number Publication Date
DE59803082D1 true DE59803082D1 (en) 2002-03-21

Family

ID=8226668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59803082T Expired - Lifetime DE59803082D1 (en) 1997-04-07 1998-04-06 Fanconi-gen ii

Country Status (5)

Country Link
JP (1) JP2000510002A (en)
AT (1) ATE213268T1 (en)
AU (1) AU723543B2 (en)
CA (1) CA2285605A1 (en)
DE (1) DE59803082D1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2325306E (en) 2005-02-25 2014-04-29 Oncotherapy Science Inc Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides

Also Published As

Publication number Publication date
AU723543B2 (en) 2000-08-31
AU7429398A (en) 1998-10-30
ATE213268T1 (en) 2002-02-15
JP2000510002A (en) 2000-08-08
CA2285605A1 (en) 1998-10-15

Similar Documents

Publication Publication Date Title
DE69534778D1 (en) Cathepsin-02-protease
EP2267010A3 (en) Activatable recombinant neurotoxins
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
ATE394484T1 (en) SMAD 6 AND ITS APPLICATIONS
WO2001075067A8 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
CA2160131A1 (en) New Bacillus Thuringiensis Strains and Their Insecticidal Proteins
AU1113999A (en) Target sequences for synthetic molecules and methods of using same
AU5906699A (en) (neisseria spp.) polypeptide, nucleic acid sequence and uses thereof
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
WO1998042827A3 (en) Gene encoding oxalate decarboxylase from aspergillus phoenicis
EP0669396A4 (en) Novel polypeptide and dna coding for the same.
ATE285474T1 (en) HAEMOPHILUS ADHESION PROTEINS
EP0685557A4 (en) Novel metalloprotease and dna coding for the same.
EP1010761A4 (en) Gene
WO2002044340A3 (en) Novel nucleic acids and polypeptides
DE59803082D1 (en) Fanconi-gen ii
EP0622464A3 (en) Nucleic acid assay procedure.
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition